HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of alemtuzumab treatment for refractory T-cell large granular lymphocytic leukemia.

AuthorsMichael D Rosenblum, James L LaBelle, Chung-Che Chang, David A Margolis, Dennis W Schauer, David H Vesole
JournalBlood (Blood) Vol. 103 Issue 5 Pg. 1969-71 (Mar 01 2004) ISSN: 0006-4971 [Print] United States
PMID14976065 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm
  • Antineoplastic Agents
  • Alemtuzumab
Topics
  • Alemtuzumab
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm (therapeutic use)
  • Antineoplastic Agents (therapeutic use)
  • Female
  • Flow Cytometry
  • Humans
  • Immunophenotyping
  • Leukemia, Lymphoid (drug therapy)
  • Leukemia, T-Cell (drug therapy)
  • Middle Aged
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: